VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 398 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,643,640 | -22.5% | 77,914 | -27.8% | 0.02% | -25.8% |
Q1 2024 | $3,411,531 | +41.1% | 107,891 | +38.4% | 0.03% | +29.2% |
Q4 2023 | $2,417,799 | +186.0% | 77,968 | +148.2% | 0.02% | +166.7% |
Q3 2023 | $845,398 | -9.4% | 31,415 | +1.4% | 0.01% | -10.0% |
Q2 2023 | $932,740 | -4.2% | 30,977 | +2.9% | 0.01% | -9.1% |
Q1 2023 | $973,700 | +29.0% | 30,098 | +14.3% | 0.01% | +22.2% |
Q4 2022 | $754,943 | +11.5% | 26,341 | -6.2% | 0.01% | 0.0% |
Q3 2022 | $677,000 | -56.9% | 28,085 | -51.1% | 0.01% | -55.0% |
Q2 2022 | $1,572,000 | -46.1% | 57,399 | -24.5% | 0.02% | -37.5% |
Q1 2022 | $2,915,000 | +16.3% | 76,009 | -2.9% | 0.03% | +18.5% |
Q4 2021 | $2,506,000 | +180.9% | 78,241 | +158.4% | 0.03% | +170.0% |
Q3 2021 | $892,000 | -4.1% | 30,284 | +10.7% | 0.01% | -9.1% |
Q2 2021 | $930,000 | +15.7% | 27,367 | +10.6% | 0.01% | +10.0% |
Q1 2021 | $804,000 | +12.6% | 24,747 | +24.9% | 0.01% | -9.1% |
Q4 2020 | $714,000 | -0.1% | 19,819 | +8.6% | 0.01% | -8.3% |
Q3 2020 | $715,000 | +7.7% | 18,254 | +0.9% | 0.01% | 0.0% |
Q2 2020 | $664,000 | +25.5% | 18,091 | -21.2% | 0.01% | +20.0% |
Q1 2020 | $529,000 | -38.5% | 22,944 | -21.9% | 0.01% | -28.6% |
Q4 2019 | $860,000 | +22.9% | 29,360 | +12.1% | 0.01% | +7.7% |
Q3 2019 | $700,000 | -12.1% | 26,196 | -15.9% | 0.01% | -13.3% |
Q2 2019 | $796,000 | +11.6% | 31,160 | -2.2% | 0.02% | +25.0% |
Q1 2019 | $713,000 | +24.4% | 31,877 | +17.3% | 0.01% | +9.1% |
Q4 2018 | $573,000 | +29.6% | 27,177 | +13.9% | 0.01% | +37.5% |
Q3 2018 | $442,000 | -12.8% | 23,862 | +5.1% | 0.01% | -20.0% |
Q2 2018 | $507,000 | 0.0% | 22,710 | -1.5% | 0.01% | 0.0% |
Q1 2018 | $507,000 | +1.6% | 23,050 | +7.4% | 0.01% | 0.0% |
Q4 2017 | $499,000 | +2.0% | 21,460 | +0.7% | 0.01% | 0.0% |
Q3 2017 | $489,000 | +3.2% | 21,310 | -0.9% | 0.01% | -9.1% |
Q2 2017 | $474,000 | -24.0% | 21,510 | -21.4% | 0.01% | -26.7% |
Q1 2017 | $624,000 | +30.0% | 27,365 | +19.2% | 0.02% | +36.4% |
Q4 2016 | $480,000 | -23.9% | 22,965 | -4.0% | 0.01% | -31.2% |
Q3 2016 | $631,000 | -9.9% | 23,930 | -5.4% | 0.02% | -23.8% |
Q2 2016 | $700,000 | – | 25,301 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |